Clinical Trials in Philadelphia

Showing 9661-9680 of 20,904 trials

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

NCT01693783

This phase II trial studies how well ipilimumab works in treating patients with human papilloma virus (HPV)-related cervical cancer that has come back or that has spread to other areas of the body. Monoclonal antibodies, such as ipilimumab, can find tumor cells and help kill them or carry tumor-killing substances to them.

Cervical AdenocarcinomaCervical Squamous Cell CarcinomaHuman Papillomavirus Infection+3 more

National Cancer Institute (NCI)42 participantsStarted Dec 2012

Duarte, California, United States • Sacramento, California, United States • South Pasadena, California, United States +10 more locations

TERMINATEDPhase 1< 1 mile

Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer

NCT02474173

This phase Ib trial studies the side effects and best dose onalespib when given together with paclitaxel in treating patients with triple negative breast cancer that has spread to other places in the body and usually cannot be cured or controlled with treatment (advanced). Onalespib works by blocking proper processing of proteins that are important for cancer growth. This results in inability of these proteins to work properly. Paclitaxel kills breast cancer cells by interfering with their ability to divide. Giving onalespib together with paclitaxel may be better than giving either one alone in treating patients with breast cancer.

Advanced Breast CarcinomaMetastatic Breast CarcinomaStage III Breast Cancer AJCC v7+5 more

National Cancer Institute (NCI)31 participantsStarted Jan 2016

Lexington, Kentucky, United States • Columbus, Ohio, United States • Philadelphia, Pennsylvania, United States +1 more locations

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer

Find Trials by Condition in Philadelphia

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

Innovative Methods to Assess Psychotherapy Practices (imAPP)

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)

SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients

TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV